MIT researchers have developed a strategy to deliver drugs to the right site in the joint. They work with nanoparticles from dendrimers, ie highly branched molecules.
Six days after treatment with the drug IGF-1, that of dendrimer Nanoparticles (dyed blue), the particles have penetrated the cartilage of the knee joint.
Photo: MIT / Brett Geiger, Jeff Wyckoff
There are now a number of highly potent molecules that cause several diseases to treat. In practice, (more…)